Bausch & Lomb Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Bausch & Lomb Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7047
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:43
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Bausch & Lomb Inc (Bausch & Lomb), a subsidiary of Valeant Pharmaceuticals International Inc, is a vision-care company with focus on the protection, enhancement and restoration of eyesight. It offers over-the-counter supplements, eye care products, contact lenses, ophthalmic pharmaceuticals, lens care products, ophthalmic surgical devices and instruments. The company develops, manufactures and markets eye health products for the treatment of a wide range of eye conditions such as glaucoma, conjunctivitis, eye allergies, dry eye and retinal diseases. It has operations across the Americas, Europe, the Middle East, Africa and Asia-Pacific. Bausch & Lomb is headquartered in Bridgewater, New Jersey, the US.

Bausch & Lomb Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Bausch & Lomb Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Bausch & Lomb Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Bausch & Lomb Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Bausch & Lomb Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Bausch & Lomb Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Bausch & Lomb Inc, Medical Equipment, Deal Details 11
Partnerships 11
Bausch & Lomb Enters Into Licensing Agreement With Cirle 11
Unilens Vision Sciences Amends Licensing Agreement With Bausch & Lomb 12
Bausch & Lomb Enters Into Distribution Agreement With PhysIOL For Hydrophilic Acrylic Intraocular Lenses 13
Leica Microsystems Enters Into Distribution Agreement With Bausch & Lomb 14
Bausch & Lomb Enters Into Agreement With Cirle For Medical Technologies 15
Bausch & Lomb Enters Into Licensing Agreement With Paragon BioTeck For Phenylephrine 16
Equity Offering 17
Bausch & Lomb Withdraws IPO 17
Acquisition 19
Bausch & Lomb Acquires Doctor’s Allergy Formula 19
Valeant Pharma Completes Acquisition Of Bausch & Lomb For US$ 8.7 Billion 20
Bausch & Lomb Completes Acquisition Of Remaining Stake In Technolas Perfect Vision From 20/10 Perfect Vision For US$631 Million 22
Abbott, Johnson & Johnson And Sanofi Mull Individual Acquisition Of Bausch & Lomb 24
Bausch & Lomb Inc – Key Competitors 26
Bausch & Lomb Inc – Key Employees 27
Bausch & Lomb Inc – Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 29
Strategy And Business Planning 29
Jul 24, 2018: Bausch + Lomb relocates company archive to new space in Rochester, NY Optics Center Facility, showcasing 165 years of science and innovation 29
Corporate Communications 30
Aug 20, 2018: Joseph Gordon Named U.S. President of Bausch + Lomb 30
Mar 30, 2017: Bausch + Lomb Announces U.S. Management Team Leadership 31
Government and Public Interest 33
Apr 19, 2018: Bausch + Lomb Reports More Than Two Million Used Contact Lens Materials Recycled Through ONE by ONE Program 33
Product News 34
Apr 27, 2018: Bausch + Lomb Will Present Scientific And Clinical Research During The Association For Research In Vision And Ophthalmology Meeting 34
Jun 20, 2017: Bausch + Lomb Unveils AMD Virtual Experience with State-of-the-Art Technology at Optometry’s Meeting 36
May 10, 2017: Bausch + Lomb Reports Updated Results of the Antibiotic Resistance Monitoring in Ocular MicRoorganisms (ARMOR) Study 37
Jan 26, 2017: Bausch + Lomb Specialty Vision Products Introduces ScleralFil Solution for Scleral Lens Insertion 38
Other Significant Developments 39
Apr 19, 2018: Title Bausch + Lomb Reports More than two Million Used Contact Lens Materials Recycled Through ONE By ONE Program 39
Nov 15, 2017: Bausch + Lomb Helps To Recycle More Than One Million Units Of Contact Lens Materials Within First Year Of Launching The ONE By ONE Recycling Program 40
Jul 17, 2017: Bausch + Lomb Launches Innovative Contact Lens Patient Savings & Rewards Program 41
Apr 17, 2017: Bausch + Lomb ONE by ONE Recycling Program Reports Over 180,000 Units of Contact Lenses and Blister Packs Saved from Landfills Since Program Launch 42
Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43

List of Tables
Bausch & Lomb Inc, Medical Equipment, Key Facts 2
Bausch & Lomb Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Bausch & Lomb Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Bausch & Lomb Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Bausch & Lomb Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Bausch & Lomb Inc, Deals By Market, 2012 to YTD 2018 9
Bausch & Lomb Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Bausch & Lomb Enters Into Licensing Agreement With Cirle 11
Unilens Vision Sciences Amends Licensing Agreement With Bausch & Lomb 12
Bausch & Lomb Enters Into Distribution Agreement With PhysIOL For Hydrophilic Acrylic Intraocular Lenses 13
Leica Microsystems Enters Into Distribution Agreement With Bausch & Lomb 14
Bausch & Lomb Enters Into Agreement With Cirle For Medical Technologies 15
Bausch & Lomb Enters Into Licensing Agreement With Paragon BioTeck For Phenylephrine 16
Bausch & Lomb Withdraws IPO 17
Bausch & Lomb Acquires Doctor’s Allergy Formula 19
Valeant Pharma Completes Acquisition Of Bausch & Lomb For US$ 8.7 Billion 20
Bausch & Lomb Completes Acquisition Of Remaining Stake In Technolas Perfect Vision From 20/10 Perfect Vision For US$631 Million 22
Abbott, Johnson & Johnson And Sanofi Mull Individual Acquisition Of Bausch & Lomb 24
Bausch & Lomb Inc, Key Competitors 26
Bausch & Lomb Inc, Key Employees 27
Bausch & Lomb Inc, Other Locations 28
Bausch & Lomb Inc, Subsidiaries 28

List of Figures
Bausch & Lomb Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Bausch & Lomb Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Bausch & Lomb Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Bausch & Lomb Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Bausch & Lomb Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Bausch & Lomb Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Bausch & Lomb Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Bausch & Lomb Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Bausch & Lomb Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Advanced Ground Systems Engineering LLC:企業の戦略・SWOT・財務情報
    Advanced Ground Systems Engineering LLC - Strategy, SWOT and Corporate Finance Report Summary Advanced Ground Systems Engineering LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Surge Energy Inc (SGY):企業の財務・戦略的SWOT分析
    Summary Surge Energy Inc (Surge) is an oil and gas company that offers acquisitions, exploration and production of crude oil and natural gas reserves. The company provides risk management and risk development drilling services. Its oil and natural gas producing properties include Shaunavon and Dodsl …
  • Strat Aero Plc (AERO):企業の財務・戦略的SWOT分析
    Summary Strat Aero Plc (Strat Aero) formally known as Remote Monitored Systems PLC is an aerospace company that offers management systems, training solutions and consultancy services to the Unmanned Aerial Vehicle (UAV) sector. The company’s services include survey and inspection services, surveilla …
  • Cleco Corporate Holdings, LLC:戦略・SWOT・企業財務分析
    Cleco Corporate Holdings, LLC - Strategy, SWOT and Corporate Finance Report Summary Cleco Corporate Holdings, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Shanghai Fosun Pharmaceutical (Group) Co Ltd (600196):製薬・医療:M&Aディール及び事業提携情報
    Summary Shanghai Fosun Pharmaceutical (Group) Co Ltd (Fosun Pharma), a subsidiary of Shanghai Fosun High Technology (Group) Co Ltd is a drug company that offers pharmaceutical products, medical diagnostic products and medical device products. The company’s pharmaceutical products include metabolism …
  • Logitech International S.A.:企業の戦略・SWOT・財務分析
    Logitech International S.A. - Strategy, SWOT and Corporate Finance Report Summary Logitech International S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Capital One Financial Corporation:企業のM&A・事業提携・投資動向
    Capital One Financial Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Capital One Financial Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …
  • CryoPort Inc (CYRX):企業の財務・戦略的SWOT分析
    CryoPort Inc (CYRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Formosa Laboratories Inc (4746):製薬・医療:M&Aディール及び事業提携情報
    Summary Formosa Laboratories Inc (Formosa Laboratories) is a producer of active pharmaceutical ingredients and UV-filters. The company’s active pharmaceutical ingredients include cholesterol and phosphate binders, anticancers, CNS agents, immunomodulators, MRI enhancing agents, anti-inflammatory and …
  • Israel Chemicals Ltd (ICL):企業の財務・戦略的SWOT分析
    Israel Chemicals Ltd (ICL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Television Francaise 1 SA:企業の戦略・SWOT・財務分析
    Television Francaise 1 SA - Strategy, SWOT and Corporate Finance Report Summary Television Francaise 1 SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Neuland Laboratories Ltd (NEULANDLAB):製薬・医療:M&Aディール及び事業提携情報
    Summary Neuland Laboratories Ltd (Neuland Lab), a subsidiary of Neuland Health Sciences Pvt Ltd is an API manufacturing service provider that manufactures active pharmaceutical ingredients, advanced intermediates; and offers chemistry related services. The company provides APIs in various therapeuti …
  • Volkswagen AG (VOW3):企業の財務・戦略的SWOT分析
    Volkswagen AG (VOW3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Alon USA Energy Inc (ALJ):企業の財務・戦略的SWOT分析
    Alon USA Energy Inc (ALJ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • DLF Limited:企業のM&A・事業提携・投資動向
    DLF Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's DLF Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Nutritional Resources Inc:企業の戦略・SWOT・財務分析
    Nutritional Resources Inc - Strategy, SWOT and Corporate Finance Report Summary Nutritional Resources Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Antitope Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Antitope Ltd (Antitope), a subsidiary of Abzena Plc is a life science company that research and develops technologies for various therapeutic areas. The company’s iTope technology is used to identify peptides; and T Cell Epitope Database is used for screening amino acid sequences from antibo …
  • BELLUS Health Inc (BLU):製薬・医療:M&Aディール及び事業提携情報
    Summary BELLUS Health Inc (BELLUS Health) is a biopharmaceutical development company, which focuses on developing drugs for rare diseases. The company’s pipeline products include BLU-5937 for chronic cough, Shigamab for STEC related hemolytic syndrome (sHUS); KIACTA for the treatment of a second ind …
  • Covalon Technologies Ltd (COV)-医療機器分野:企業M&A・提携分析
    Summary Covalon Technologies Ltd (Covalon) is a researcher, developer and commercialization of medical devices and healthcare technologies. The company offers advanced wound solutions, infection prevention products and perioperative care products. Covalon offers wound care products such as collagen …
  • Chubu Electric Power Co Inc (9502):石油・ガス:M&Aディール及び事業提携情報
    Summary Chubu Electric Power Co Inc (Chubu) is an energy utility. It generates and procures electricity; and offers electric network related services. The company produces electricity using hydro, thermal, nuclear and renewable sources. Chubu has interests in upstream and midstream energy fields. It …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆